The Division of Pulmonary, Allergy, and Critical Care Medicine (PACCM) at the University of Pittsburgh School of Medicine has a tradition of commitment to the training of academic pulmonary investigators. In parallel with emerging lung research, prior T-32 support, had initially focused on studying the human pathophysiology of lung diseases. Subsequent training directions have focused on the cellular and molecular physiology of lung disorders. The current proposal represents the synthesis of these efforts under new leadership and direction. The goal of the PACCM Multidisciplinary Training Program (PACCM MTP) is to prepare physicians and PhDs for biomedical research careers by providing a concentrated, in-depth research experience. This proposal will outline the comprehensive resources available to support six postdoctoral fellows yearly. This program is designed to foster a rigorous approach to scientific inquiry in basic science or clinical investigation. Four thematic units of research are emphasized: (1) cell biology and molecular immunology of the lung; (2) lung and vascular injury; (3) human pathophysiology; and 4) epideniiology/bioinformatics. The outstanding collaborations established through prior training grant proposals (Drs Pitt and Frizzell), ongoing growth in Departmental research programs (Drs Kapoor and Roberts), and new collaborative efforts (Drs. Kleyman, A.Ray, P.Ray, Billiar, and Bahar) provide a trainer group of tremendous breadth and international quality. A comprehensive didactic curriculum will provide the tools necessary for training in a new era of genomics research. The training program has successfully experienced a transition in leadership. Dr. Augustine Choi has been recruited from Yale University after an exhaustive national search. This proposal will outline a deep commitment of resources from the University and Department of Medicine to maintain and expand the University of Pittsburgh as a premier program for lung investigation. A newly constructed $3 million dollar Respiratory Science Center will synergize the basic research efforts of PACCM faculty and collaborators (Pitt and Billiar). Strengthening of the program through selective faculty recruitment will also be outlined. The research profile of the Division has increased by greater than 2-fold in the short 9 months since Dr. Choi?s arrival in Pittsburgh. The outstanding training record of the program faculty will be outlined. Dr. Choi?s training and investigative record will confirm that he is uniquely qualified to provide an unparalleled training opportunity for academic leaders of tomorrow. The institutional and departmental commitment is clearly in focus to maintain and expand the University of Pittsburgh as a premier program for basic and clinical research training in lung diseases. The PACCM MTP will use the tradition of the past with new energy and resources, to achieve a comprehensive training opportunity for the future.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007563-17
Application #
6622736
Study Section
Special Emphasis Panel (ZHL1-CSR-M (F1))
Program Officer
Rothgeb, Ann E
Project Start
1984-07-01
Project End
2007-06-30
Budget Start
2003-07-01
Budget End
2004-06-30
Support Year
17
Fiscal Year
2003
Total Cost
$370,377
Indirect Cost
Name
University of Pittsburgh
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Kitsios, Georgios D; Rojas, Mauricio; Kass, Daniel J et al. (2018) Microbiome in lung explants of idiopathic pulmonary fibrosis: a case-control study in patients with end-stage fibrosis. Thorax 73:481-484
Zank, Daniel C; Bueno, Marta; Mora, Ana L et al. (2018) Idiopathic Pulmonary Fibrosis: Aging, Mitochondrial Dysfunction, and Cellular Bioenergetics. Front Med (Lausanne) 5:10
Scheunemann, Leslie P; Khalil, Ramy; Rajagopal, Padma S et al. (2018) Development and Pilot Testing of a Simulation to Study How Physicians Facilitate Surrogate Decision-Making Based on Critically Ill Patients' Values and Preferences. J Pain Symptom Manage :
Rose, Jason J; Nouraie, Mehdi; Gauthier, Marc C et al. (2018) Clinical Outcomes and Mortality Impact of Hyperbaric Oxygen Therapy in Patients With Carbon Monoxide Poisoning. Crit Care Med 46:e649-e655
Hensley, Matthew K; Levine, Andrea; Gladwin, Mark T et al. (2018) Emerging therapeutics in pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 314:L769-L781
Lennox, Alison T; Coburn, Stefanie L; Leech, John A et al. (2018) ATP12A promotes mucus dysfunction during Type 2 airway inflammation. Sci Rep 8:2109
Evankovich, John; Lear, Travis; Mckelvey, Alison et al. (2017) Receptor for advanced glycation end products is targeted by FBXO10 for ubiquitination and degradation. FASEB J 31:3894-3903
Meijles, Daniel N; Sahoo, Sanghamitra; Al Ghouleh, Imad et al. (2017) The matricellular protein TSP1 promotes human and mouse endothelial cell senescence through CD47 and Nox1. Sci Signal 10:
Weathington, Nathaniel M; Kanth, Shreya M; Gong, Qiaoke et al. (2017) IL-4 Induces IL17Rb Gene Transcription in Monocytic Cells with Coordinate Autocrine IL-25 Signaling. Am J Respir Cell Mol Biol 57:346-354
Gladwin, Mark T (2017) Translational Advances in the Field of Pulmonary Hypertension Bench to Bedside: How Fundamental Discoveries in Science Are Advancing Our Understanding and Therapy of Pulmonary Arterial Hypertension. Am J Respir Crit Care Med 195:1-3

Showing the most recent 10 out of 114 publications